Dermotone Cellulite Contouring Gel 120g
Dermotone
R800.00
Description
Say Goodbye To The Orange Peel Effect!
Dermotone cellulite contouring gel is a blend of pharmaceutical-based ingredients known to reduce the appearance of cellulite, Dermotone contains aminophylline which is the industry standard cellulite reduction ingredient. Dermotone will stimulate blood flow and blood circulation to cellulite-laden areas. A non-sticky gel will deliver a blend of ingredients such as aminophylline, raspberry ketones, acetyl l carnitine, caffeine, and menthol to help contour your stubborn, problematic, cellulite areas.
One of the leading causes of cellulite is the lack of blood flow and blood circulation to a cellulite-laden or stubborn fatty area. Dermotone will aid in increasing blood flow, this will be seen due to the redness in the skin, and increase the blood circulation to the fatty tissue with the help of menthol and other product ingredients.
Dermotone contains Aminophylline, this is the industry standard ingredient for cellulite treatment. Many doctors inject Aminophylline through the skin to cellulite-laden areas, whereas Dermotone uses a powerful delivery system that allows the Aminophylline to pass through the skin to the adipose fatty tissue.
Aminophylline simulates Beta2 receptors which forces the body to use fatty adipose tissue for energy. Acetyl L-carnitine is another ingredient which forces the mitochondria of the cells in the body to utilize the free fatty acids released by the aminophylline.
Dermotone utilizes the key ingredient, caffeine, which is a powerful stimulant that can increase the rate in which the body utilizes the freed up fatty acids.
Raspberry ketones is another key ingredient as it can cause the fat within cells to be broken down more effectively, helping your body burn fat faster. Raspberry ketones are also known to increase levels of adiponectin in the body. Adiponectin is a hormone that helps to regulate the metabolism.
You must be logged in to post a review.
Reviews
There are no reviews yet.